Clinical trials
Autism Spectrum Disorder trials in Israel
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
29 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2007 | 1 |
| 2008 | 2 |
| 2010 | 1 |
| 2011 | 1 |
| 2013 | 1 |
| 2014 | 1 |
| 2015 | 1 |
| 2016 | 1 |
| 2017 | 2 |
| 2018 | 3 |
| 2019 | 1 |
| 2020 | 2 |
| 2021 | 5 |
| 2022 | 2 |
| 2023 | 1 |
| 2024 | 1 |
| 2025 | 1 |
| 2026 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 14 |
| Unknown status | 8 |
| Recruiting | 3 |
| Terminated | 2 |
| Not yet recruiting | 1 |
| Suspended | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Sheba Medical Center | 4 |
| Bar-Ilan University, Israel | 3 |
| Hadassah Medical Organization | 3 |
| Hebrew University of Jerusalem | 2 |
| Meir Medical Center | 2 |
| University of Haifa | 2 |
| Ariel University | 1 |
| Assaf Harofeh MC | 1 |
| Assaf-Harofeh Medical Center | 1 |
| Bazelet Nehushtan LtD. | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Autism Spectrum Disorder | 29 |
| Autistic Disorder | 11 |
| Attention Deficit Disorder with Hyperactivity | 1 |
| Child Development Disorders, Pervasive | 1 |
| Intellectual Disability | 1 |
| Language Development Disorders | 1 |
| Lymphoma, Follicular | 1 |
| Marijuana Abuse | 1 |
| Occupational Stress | 1 |
| Premature Birth | 1 |
Trials
Showing 26 to 29 of 29. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.